Maxcyte (MXCT) Change in Acquisitions & Divestments (2020 - 2026)

Maxcyte (MXCT) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $28.0 million in Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 39.91% year-over-year to $28.0 million in Q1 2026; TTM through Mar 2026 was $137.2 million, a 20.06% decrease from a year earlier, with the FY2025 full-year figure at $155.8 million, down 2.31% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $28.0 million, down from $38.2 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for MXCT reached as high as $200.8 million in Q1 2022 and fell as low as $6.5 million in Q2 2022.
• Historically, Change in Acquisitions & Divestments has averaged $55.4 million across 5 years, with a median of $43.0 million in 2024.
• Across the five-year window, Change in Acquisitions & Divestments soared 1154.97% in 2022 and tumbled 61.29% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at $52.5 million in 2022, then gained by 26.19% to $66.2 million in 2023, then plunged by 53.21% to $31.0 million in 2024, then advanced by 23.1% to $38.2 million in 2025, then decreased by 26.63% to $28.0 million in 2026.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $28.0 million in Q1 2026, $38.2 million in Q4 2025, and $40.0 million in Q3 2025.